COMMUNIQUÉS West-GlobeNewswire

K2M Receives FDA Clearance Including Surgical Guidance that Enhances MESA® Platform Using Patient-Specific Rods & Rails
10/10/2018
Dual Differential Correction (DDC™) Philosophy & Technique helps restore sagittal balance in patients LEESBURG, Va., Oct. 10, 2018 (GLOBE NEWSWIRE) -- K2M Group Holdings, Inc. (NASDAQ:KTWO) (the "Company" or "K2M [...]
Novartis announces new data from the first direct head-to-head trial to demonstrate superior efficacy of Gilenya® over Copaxone® in patients with relapsing remitting multiple sclerosis
10/10/2018
Topline findings from ASSESS show adult relapsing remitting multiple sclerosis (RRMS) patients taking Gilenya (fingolimod) 0.5mg experienced significantly fewer relapses than patients on Copaxone (glatiramer acetate) [...]
Constellation Pharmaceuticals Enhances and Expands Phase 2 MANIFEST Study of CPI-0610 in Myelofibrosis
10/10/2018
– Amends second-line trial design to stratify for transfusion dependence based on positive preliminary data – – Expands study to include an additional arm evaluating CPI-0610 as first-line therapy in combination with [...]
Evidence on the Safety and Efficacy of Ortho-R in a Large Animal Model Presented at 2018 SICOT World Congress
10/10/2018
KIRKLAND, Quebec, Oct. 10, 2018 (GLOBE NEWSWIRE) -- Ortho Regenerative Technologies Inc. ( CSE: ORTH ) (“ Ortho RTi ” or the “ Corporation” ), an emerging Orthopaedic and Sports Medicine technology company, announced [...]
SeaSpine Commences Public Offering of Common Stock
10/10/2018
CARLSBAD, Calif., Oct. 10, 2018 (GLOBE NEWSWIRE) -- SeaSpine Holdings Corporation (NASDAQ: SPNE) (“SeaSpine” or the “Company”), a global medical technology company focused on surgical solutions for the treatment of [...]
Loop Industries Reports Second Quarter of Fiscal 2019 Consolidated Results
10/10/2018
Announced joint venture with Indorama Ventures to manufacture and commercialize Loop’s technology Announced multi-year supply agreement with Pepsico for Loop branded 100% sustainable plastic from Loop’s joint venture [...]
Conformis to Host Third Quarter 2018 Financial Results Webcast on October 31, 2018
10/10/2018
BILLERICA, Mass., Oct. 10, 2018 (GLOBE NEWSWIRE) -- Conformis, Inc. (NASDAQ: CFMS) announced today that it will host a webcast on Wednesday, October 31, 2018, at 4:30 p.m. Eastern Time to discuss its financial results [...]
Histogenics Corporation Announces Closing of Public Offering of Common Stock and Warrants
10/10/2018
WALTHAM, Mass., Oct. 10, 2018 (GLOBE NEWSWIRE) -- Histogenics Corporation (Histogenics) (Nasdaq: HSGX), a leader in the development of restorative cell therapies, today announced the closing of its previously announced [...]
CRISPR Therapeutics and Vertex Announce FDA Has Lifted the Clinical Hold on the Investigational New Drug Application for CTX001 for the Treatment of Sickle Cell Disease
10/10/2018
ZUG, Switzerland and BOSTON and CAMBRIDGE, Mass., Oct. 10, 2018 (GLOBE NEWSWIRE) -- CRISPR Therapeutics (NASDAQ:CRSP), a biopharmaceutical company focused on creating transformative gene-based medicines for serious [...]
JDRF celebrates Health Canada’s new licence for technology that will improve the lives of people with type 1 diabetes
10/10/2018
Approval of Canada’s first Hybrid Closed-Loop System will help Canadians with type 1 diabetes keep their blood sugar levels in an optimal range for a greater amount of time TORONTO, Oct. 10, 2018 (GLOBE NEWSWIRE) -- [...]
SuperSonic Imagine will present its new ultrasound platform, the Aixplorer MACH 30, at the French Radiology Days (JFR) from October 12 - 15 in Paris
10/10/2018
AIX-EN-PROVENCE, France, Oct. 10, 2018 (GLOBE NEWSWIRE) -- SuperSonic Imagine (Euronext: SSI FR0010526814), a company specialised in ultrasound medical imaging, will for the first time present its new Aixplorer MACH 30 [...]
bioAffinity Licenses CyPath® Lung to Precision Pathology Services
10/10/2018
SAN ANTONIO, Oct. 10, 2018 (GLOBE NEWSWIRE) -- bioAffinity Technologies, a privately held biotech company, today announced a licensing agreement with Precision Pathology Services for the continued development and [...]
OSE Immunotherapeutics and Oncology Physician Network GERCOR Announce Submission of Investigational New Drug Application to Evaluate Tedopi® in Combination with Nivolumab in Pancreatic Cancer
10/10/2018
The Phase 2 clinical trial of Tedopi® in pancreatic cancer will be sponsored by the oncology group GERCOR The study will explore Tedopi®’s potential in an additional oncology indication NANTES, France, Oct. 10, 2018 ( [...]
LE GROUPE EUROBIO SCIENTIFIC CONFIRME SON ELIGIBILITE AU DISPOSITIF PEA-PME
10/10/2018
LE GROUPE EUROBIO SCIENTIFIC CONFIRME SON ELIGIBILITE AU DISPOSITIF PEA-PME Paris, le 10 octobre 2018 - 17h45 Eurobio Scientific (FR0013240934, ALERS, éligible PEA-PME), groupe français leader dans le diagnostic médical [...]
Pharmaceutical Executive Honors Emerging Pharma Leaders
10/10/2018
Awards program recognizes inspiring and distinguished professionals in the industry ISELIN, N.J., Oct. 10, 2018 (GLOBE NEWSWIRE) -- UBM Life Sciences Group’s Pharmaceutical Executive announced honorees of the 2018 [...]
NeuroMetrix, Inc. Announces Date for 2018 Third Quarter Financial Results Conference Call
10/10/2018
WALTHAM, Mass., Oct. 10, 2018 (GLOBE NEWSWIRE) -- NeuroMetrix, Inc. (NASDAQ:NURO) announced today that it plans to issue its 2018 third quarter financial results before the opening of the market on Wednesday, October 17 [...]
MediPharm Labs Corp. and Emerald Health Therapeutics, Inc. Sign Cannabis Concentrate Program Agreement
10/10/2018
TORONTO, Oct. 10, 2018 (GLOBE NEWSWIRE) -- MediPharm Labs Corp. (" MediPharm ") (TSXV: LABS) is pleased to announce that it has entered into a Cannabis Concentrate Program Agreement (the " Agreement ") with Emerald [...]
Imprivata Enters into Agreement with ICU Medical to Improve Security for Infusion Pumps
10/10/2018
LEXINGTON, Mass., Oct. 10, 2018 (GLOBE NEWSWIRE) -- Imprivata® , the healthcare IT security company, today announced a new collaboration with ICU Medical Inc., a leader in the development, manufacture, and sale of [...]
CO2 GRO is pleased to announce the Appointment of Dr. Matt Julius as Acting Chief Science Officer Effective January 2019
10/10/2018
TORONTO, Oct. 10, 2018 (GLOBE NEWSWIRE) -- Toronto based CO2 GRO Inc. (“ GROW ” or the “ Company ”) (TSX-V: GROW, OTCQB: BLONF) is pleased to announce that Dr. Matt Julius, Ph.D., Professor of Biology, St. Cloud State [...]

Pages